Skip to main content
Equibles

Soleus Capital Management, L.P.

Position in VIR — Vir Biotechnology, Inc.

CIK 1802630 GREENWICH, CT
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$10,190,000
-$7,747,920 QoQ
Shares Held
1,000,000
-50.0% QoQ
Ownership
0.591%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#27
of 237 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,753,981,438 across 64 Biotechnology names. VIR ranks #34 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 KRYS
Krystal Biotech, Inc.
 939,254 $349,092,534
2 CELC
Celcuity Inc.
 1,704,318 $178,305,749
3 TGTX
Tg Therapeutics, Inc.
 2,927,895 $160,858,551
4 RIGL
Rigel Pharmaceuticals Inc
 1,843,504 $72,117,876
5 VCEL
Vericel Corp
 1,459,152 $64,917,672
6 PRAX
Praxis Precision Medicines, Inc.
 177,517 $59,430,916
7 GERN
Geron Corp
 42,808,659 $54,795,083
8 ERAS
Erasca, Inc.
 2,700,000 $49,464,000

All Filings in VIR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,190,000 1,000,000
2026-03-31 $17,937,920 2,002,000